Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 401–500 of 1,001
Vascular Complications After Radiotherapy in Head and Neck Free Flap Reconstruction
Tall, J., Christersdottir, T., Skogh, A.-C. D., Arnander, C., & Halle, M. (2014) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000000081 · Cited by 65
The Diagnostic and Prognostic Value of Echocardiographic Strain
Singh, A., Voss, W. B., Lentz, R. W., Thomas, J. D., & Akhter, N. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1152 · Cited by 69
Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade
Christersdottir, T., Pirault, J., Gisterå, A., Bergman, O., Gallina, A. L., Baumgartner, R., Lundberg, A. M., Eriksson, P. O., Yan, Z.-Q., Paulsson‐Berne, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz206 · Cited by 67
Sex Differences in Coronary Atherosclerosis
Sato, Y., Kawakami, R., Sakamoto, A., Cornelissen, A., Mori, M., Kawai, K., Ghosh, S. K. B., Romero, M. E., Kolodgie, F. D., Finn, A. V., et al. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-00980-5 · Cited by 67
Mann, G. B., Skandarajah, A. R., Zdenkowski, N., Hughes, J., Park, A., Petrie, D., Saxby, K., Grimmond, S. M., Murugasu, A., Spillane, A. J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)02476-5 · Cited by 71
Moignier, A., Broggio, D., Derreumaux, S., Beaudré, A., Girinsky, T., Paul, J., Drubay, D., Lefkopoulos, D., Franck, D., Aubert, B., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.07.043 · Cited by 64
Patel, S. A., Lu, H., Nyamwanda, J. A., Jimenez, R., Taghian, A. G., MacDonald, S. M., & Depauw, N. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2017.06.006 · Cited by 64
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
Jimenez, R., Abdou, Y. G., Anderson, P. R., Barry, P. N., Bradfield, L., Bradley, J. A., Heras, L. D., Khan, A. J., Matsen, C. B., Rabinovitch, R. A., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-01747 · Cited by 63
“134,135 Although a dose-dependent relationship between cardiac exposure to RT and heart disease has been demonstrated in several landmark studies, 136-140 no safe threshold has been established to prevent major cardio-vascular events.”
Cody, J. J., Markert, J. M., & Hurst, D. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092919 · Cited by 67
“As examples, two recent studies have underscored the long term risks of heart disease posed to breast cancer patients treated with either trastuzumab or anthracycline chemotherapeutics [2] as well as radiotherapy [3].”
BackgroundAzimzadeh, O., Sievert, W., Sarioglu, H., Yentrapalli, R., Barjaktarović, Ž., Sriharshan, A., Ueffing, M., Janik, D., Aichler, M., Atkinson, M. J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400071g · Cited by 65
Palumbo, I., Palumbo, B., Fravolini, M. L., Marcantonini, M., Perrucci, E., Latini, M., Falcinelli, L., Sabalich, I., Tranfaglia, C., Schillaci, G., et al. (2015) · The Breast · doi:10.1016/j.breast.2015.10.004 · Cited by 63
“Although a potential increase in cardiac events was described after RT, the available studies do not consider the impact of newer commonly utilized RT techniques which allow heart sparing [12].”
BackgroundBourland, J. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00006-x · Cited by 67
Brownlee, Z., Garg, R., Listo, M., Zavitsanos, P. J., Wazer, D. E., & Huber, K. E. (2018) · Gland Surgery · doi:10.21037/gs.2018.01.05 · Cited by 63
“They found no correlation with pre-existing cardiac risk factors (11).”
BackgroundRadiation and the heart: systematic review of dosimetry and cardiac endpoints
Niska, J. R., Thorpe, C. S., Allen, S., Daniels, T. B., Rule, W. G., Schild, S. E., Vargas, C., & Mookadam, F. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1538785 · Cited by 63
“4% increase in major coronary events per Gy MHD [44], 13% increase in CTA abnormalities per Gy to the coronary artery origins [65], 7.”
Backgroundvan den Bogaard, V. A. B., Spoor, D. S., van der Schaaf, A., van Dijk, L. V., Schuit, E., Sijtsema, N. M., Langendijk, J. A., Maduro, J. H., & Crijns, A. P. G. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.03.004 · Cited by 62
Cardiac risk in the treatment of breast cancer: assessment and management
Valachis, A., & Nilsson, C. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s47227 · Cited by 70
“When estimating the risk–benefit of radiotherapy in the individual patient, it is also important to consider other factors that increase the risk of RIHD, such as smoking, diabetes, or a history of ischemic heart disease.(12,13) The only way of totally avoiding the risk of RIHD is to omit radiotherapy.”
Lee, H. Y., Chang, J. S., Lee, I. J., Park, K., Kim, Y. B., Suh, C., Kim, J. W., & Keum, K. C. (2013) · Radiation Oncology Journal · doi:10.3857/roj.2013.31.4.239 · Cited by 70
“However, many studies have demonstrated increased cardiac mortality and morbidity after breast radiotherapy [3-5].”
BackgroundHow could breast cancer molecular features contribute to locoregional treatment decision making?
Tsoutsou, P. P., Vozenin, M., Durham, A., & Bourhis, J. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.006 · Cited by 62
“…planning permit dose reductions to critical organs, such as the heart, any dose to the heart is associated with a modest risk of coronary events (Darby et al., 2013), and therefore more comprehensive RT could eventually be refined using molecular indicators of recurrence risk, as well as…”
BackgroundDumane, V. A., Saksornchai, K., Zhou, Y., Hong, L. X., Powell, S. N., & Ho, A. Y. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1132-9 · Cited by 62
“Finally, a large population-based study conducted in Swedish and Danish patients demonstrated a dose-response relationship between mean heart dose and the development of major cardiac events in breast cancer patients treated with radiation [14].”
BackgroundAdvances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity
Schlaak, R. A., SenthilKumar, G., Boerma, M., & Bergom, C. R. (2020) · Cancers · doi:10.3390/cancers12020415 · Cited by 62
“In breast cancer patients, it has been estimated that there is an approximately 4–16% relative increase in heart disease and/or major coronary events for each 1 Gy in mean heart dose received [6,9,10].”
BackgroundResultTahir, E., Azar, M. E., Shihada, S., Seiffert, K., Goy, Y., Beitzen‐Heineke, A., Molwitz, I., Muellerleile, K., Stehning, C., Schön, G., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08260-7 · Cited by 64
Radiation-Induced Heart Disease
Quintero-Martinez, J. A., Cordova-Madera, S. N., & Villarraga, H. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010146 · Cited by 61
“One study performed in breast cancer patients suggested that CAD may develop as early as 5 years post RT [28].”
BackgroundPolgár, C., Kahán, Z., Ivanov, O., Chorvath, M., Ligačová, A., Csejtei, A., Gábor, G., Landherr, L., Mangel, L., Mayer, A., et al. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610378 · Cited by 61
An overview of radiation-induced heart disease
Ellahham, S. H., Khalouf, A., Elkhazendar, M., Dababo, N., & Manla, Y. (2022) · Radiation Oncology Journal · doi:10.3857/roj.2021.00766 · Cited by 61
“ery 1 Gy increase in MHD, with damage starting within 5 years and extending up to 20 years of exposure [49].”
BackgroundHypofractionation with simultaneous integrated boost for early breast cancer
Dellas, K., Vonthein, R., Zimmer, J., Dinges, S., Boicev, A. D., Andreas, P., Fischer, D., Winkler, C., Ziegler, A., Dunst, J., et al. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0658-5 · Cited by 61
“The issue of late cardiac toxicity has recently been extensively discussed after a publication in the New England Journal of Medicine [16].”
BackgroundOverdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality
Barratt, A. L. (2015) · BMJ · doi:10.1136/bmj.h867 · Cited by 61
Eldredge-Hindy, H., Lockamy, V. L., Crawford, A. G., Nettleton, V., Werner‐Wasik, M., Siglin, J., Simone, N. L., Sidhu, K., & Anne, P. R. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.06.004 · Cited by 66
“Methods & Materials—Patients with Stages 0-III left breast cancer (LBC) were enrolled and underwent simulation with both free breathing (FB) and ABC for comparison of dosimetry.”
BackgroundInfluentialHerrmann, J., & Lerman, A. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.07.003 · Cited by 61
“[92] Darby SC, Ewertz M, McGale P, et al.”
BackgroundInfluentialAdjuvant trastuzumab: a 10-year overview of its benefit
Lambertini, M., Ponde, N. F., Solinas, C., & de Azambuja, E. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1264876 · Cited by 63
“Radiotherapy [83,84], anthracyclines [85,86] and anti-HER2 agents [87,88] are implicated in causing potentially short- and long-term clinically important cardiac dysfunction.”
BackgroundPericardial Involvement in Cancer
Chahine, J., Shekhar, S., Mahalwar, G., Imazio, M., Collier, P. H., & Klein, A. L. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.092 · Cited by 65
Kim, D. Y., Park, M., Youn, J., Lee, S., Choi, J. H., Jung, M., Kim, L. S., Kim, S. H., Han, S., & Ryu, K.-H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021931 · Cited by 62
“35,36 The incidence of MACE is strongly associated with the radiation dose delivered to the heart, for which there is no apparent threshold, 37,38 and the cardiovascular risk of left-sided breast radiation therapy can be increased by the concomitant use of chemotherapy.”
Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Picano, E., Ciampi, Q., Cortigiani, L., Arruda-Olson, A. M., Daros, C. B., Pretto, J. L. D. C. E. S., Cocchia, R., Bossone, E., Merli, E., Kane, G. C., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163641 · Cited by 60
“The estimated incidence of major cardiac events related to ischemic heart disease is 30% at 10 years post-treatment in female patients with radiotherapy post-breast cancer [41].”
BackgroundLiu, R., Charyyev, S., Wahl, N., Liu, W., Kang, M., Zhou, J., Yang, X., Baltazar, F., Palkowitsch, M., Higgins, K. A., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.01.048 · Cited by 60
Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis
Galimzhanov, A. M., Istanbuly, S., Tun, H. N., Özbay, B., Alasnag, M. A., Ky, B., Lyon, A. R., Kayıkçıoğlu, M., Tenekecioğlu, E., Panagioti, M., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad243 · Cited by 62
Kim, K., Kim, M. M., Skoufos, G., Diffenderfer, E. S., Motlagh, S. A. O., Kokkorakis, M., Koliaki, I., Morcos, G., Shoniyozov, K., Griffin, J., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.01.224 · Cited by 60
Cancer therapy-induced cardiotoxicity: mechanisms and mitigations
Shil, S., Kumar, P., & Mumbrekar, K. D. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10531-0 · Cited by 64
“Damaging effects on the heart can be seen after doses as low as 2 Gy, and there is no apparent “safe” dose [132].”
Radiation Treatment in Older Patients: A Framework for Clinical Decision Making
Smith, G. L., & Smith, B. D. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1168 · Cited by 68
“be more frequent in patients receiving radiation dose to heart if there is underlying heart disease).(32) Hence, a thorough competing-risk assessment requires consideration of the patient’s age, comorbid status, performance status,”
BackgroundKirova, Y., Hijal, T., Campana, F., Fournier‐Bidoz, N., Stilhart, A., Dendale, R., & Fourquet, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.10.038 · Cited by 60
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures
Yu, A. F., & Jones, L. W. (2016) · Cardio-Oncology · doi:10.1186/s40959-016-0011-5 · Cited by 68
“4 % for each additional 1Gy of radiation to the heart, and an increase in cardiac risk was present even at low radiation doses ≤ 4 Gy [28].”
BackgroundCaro-Morán, E., Fernández‐Lao, C., Galiano‐Castillo, N., Cantarero‐Villanueva, I., Arroyo‐Morales, M., & Díaz‐Rodríguez, L. (2015) · Biological Research For Nursing · doi:10.1177/1099800414568100 · Cited by 60
“Radiotherapy can also increase the risk of heart disease (Darby et al., 2013).”
BackgroundGharzai, L. A., Verma, V., Denniston, K. A., Bhirud, A. R., Bennion, N. R., & Lin, C. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158916 · Cited by 60
“4% increased risk of cardiac events per Gray of mean heart RT dose [12], a value that could be higher when accounting for preexisting comorbidities [13].”
BackgroundVenous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry
Guy, J., Bertoletti, L., Magné, N., Rancoule, C., Mahé, I., Font, C., Sanz, O., Martín‐Antorán, J. M., Pace, F., Vela, J. R., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.006 · Cited by 60
Walker, V., Lairez, O., Fondard, O., Pathak, A., Pinel, B., Chevelle, C., Franck, D., Jimenez, G., Camilleri, J., Panh, L., et al. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1408-8 · Cited by 63
Yu, F.-J., Li, Y., Zou, J., Jiang, L., Wang, C., Tang, Y., Gao, B., Luo, D., & Jiang, X. (2019) · Journal of International Medical Research · doi:10.1177/0300060519842781 · Cited by 59
“Breast cancer is the most prevalent cancer and the leading cause of cancer-related death in women, accounting for 23% of all cancers and 14% of cancer-related deaths worldwide.(1,2) Breast cancer is mostly treated with surgery and chemotherapy, which are usually used in combination.”
BackgroundRetractedLoap, P., Kirov, K. M., & Kirova, Y. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103121 · Cited by 65
Nagane, M., Yasui, H., Kuppusamy, P., Yamashita, T., & Inanami, O. (2021) · Journal of Radiation Research · doi:10.1093/jrr/rrab032 · Cited by 62
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.003 · Cited by 63
Progress and controversies: Radiation therapy for invasive breast cancer
Jagsi, R. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21209 · Cited by 64
“A recent population-based case-control study has highlighted the importance of minimizing the radiation dose to the heart.(163) However, it is important to note that the net survival benefit of radiation therapy that was documented in the trials discussed above and in the metaanalysis already accounted for any adverse…”
BackgroundArterial thrombosis and cancer
Aronson, D., & Brenner, B. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.01.003 · Cited by 60
Dent, S. F., Kikuchi, R., Kondapalli, L., Ismail-Khan, R. R., Brezden‐Masley, C., Barac, A., & Fradley, M. G. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_286019 · Cited by 66
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy
Harries, I., Liang, K., Williams, M. G. L., Berlot, B., Biglino, G., Lancellotti, P., Plana, J. C., & Bucciarelli‐Ducci, C. (2020) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.04.011 · Cited by 68
“4% per Gray), starting 5 years after exposure (81).”
BackgroundDesideri, I., Loi, M., Francolini, G., Becherini, C., Livi, L., & Bonomo, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01708 · Cited by 62
“Nonetheless, a distinct dose threshold could not be identified (89).”
BackgroundMilo, M. L. H., Thorsen, L. B. J., Johnsen, S. P., Nielsen, K. M., Valentin, J. B., Alsner, J., & Offersen, B. V. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.01.010 · Cited by 59
Radiation injury and gut microbiota-based treatment
Wang, W., Cui, B., Nie, Y., Sun, L., & Zhang, F. (2023) · Protein & Cell · doi:10.1093/procel/pwad044 · Cited by 58
“The risk of heart injury increases by 7.4% when the radiation dose increases by 1 Gy (Darby et al .”
BackgroundInfluentialMa, C., Zhang, W.-Z., Lu, J.-Y., Wu, L., Wu, F., Huang, B.-T., Lin, Y., & Li, D. (2015) · Scientific Reports · doi:10.1038/srep12274 · Cited by 58
Kim, K., Oh, K. S., Park, D. Y., Lee, J., Lee, B. S., Kim, I. S., Kim, K., Kwon, I. C., Sang, Y. K., & Yuk, S. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.009 · Cited by 60
Toohey, K. L., Pumpa, K. L., Arnolda, L., Cooke, J., Yip, D., Craft, P., & Semple, S. (2016) · PeerJ · doi:10.7717/peerj.2613 · Cited by 59
Wennstig, A.-K., Wadsten, C., Garmo, H., Fredriksson, I., BLOMQVIST, C. P., Holmberg, L., Nilsson, G., & Sund, M. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-1249-2 · Cited by 58
“Previous studies have shown that the risk of radiation-induced IHD begins within a few years from RT and continues for a long period of time, with the highest risk seen between 10 and 14 years from the RT [2], and it is thus likely that the elevation in risk of IHD in women receiving leftsided RT in the present study…”
BackgroundKirsch, D. G., Diehn, M., Cucinotta, F. A., & Weichselbaum, R. R. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.060 · Cited by 58
“In addition to cancer risks, low doses of ionizing radiation have been shown to increase lifetime risks of several components of circulatory disease [18,19].”
Vaidya, J. S., Bulsara, M. K., Wenz, F. K., Joseph, D. J., Saunders, C. M., Massarut, S., Flyger, H. L., EIERMANN, W., Alvarado, M. D., Esserman, L. J., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.03.022 · Cited by 60
Statin-Regulated Efferocytosis in Physiological and Pathological Conditions
Tajbakhsh, A., Hayat, S. M. G., Askari, H., Savardashtaki, A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108282 · Cited by 63
Joo, J. H., Kim, S. S., Ahn, S. D., Kwak, J., Jeong, C., Ahn, S., Son, B., & Lee, J. W. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0573-7 · Cited by 57
“[3] have reported that the rates of major coronary events increased by 7.”
BackgroundInfluentialColeman, M. A., Sasi, S. P., Onufrak, J., Natarajan, M., Manickam, K., Schwab, J., Muralidharan, S., Peterson, L. E., Alekseyev, Y. O., Yan, X., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00050.2015 · Cited by 56
Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation
Vega, R. B. M., Ishaq, O. F., Raldow, A. C., Perez, C. A., Jimenez, R., Scherrer‐Crosbie, M., Bussière, M. R., Taghian, A. G., Sher, D. J., & MacDonald, S. M. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.02.031 · Cited by 58
DeBo, R. J., Lees, C. J., Dugan, G. O., Caudell, D. L., Michalson, K. T., Hanbury, D. B., Kavanagh, K., Cline, J. M., & Register, T. C. (2016) · Radiation Research · doi:10.1667/rr14357.1 · Cited by 57
“4% per Gy of incidental exposure to the heart with no apparent threshold for increased risk (22).”
Healthy lifestyle impact on breast cancer-specific and all-cause mortality
Heitz, A., Baumgartner, R., Baumgartner, K. B., & Boone, S. D. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4467-2 · Cited by 68
“radiotherapy that may exacerbate the underlying non-cancer diseases such as cardiovascular disease [58, 59].”
Trivedi, S. J., Choudhary, P., Lo, Q., Sritharan, H. P., Iyer, A., Batumalai, V., Delaney, G. P., & Thomas, L. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.10.023 · Cited by 57
Salerno, E. A., Rowland, K. M., Kramer, A. F., & McAuley, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5589-1 · Cited by 59
Modern Radiotherapy and Risk of Cardiotoxicity
Koutroumpakis, E., Palaskas, N. L., Lin, S. H., Abe, J., Liao, Z. X., Banchs, J. A., Deswal, A. M., & Yusuf, S. W. (2020) · Chemotherapy · doi:10.1159/000510573 · Cited by 59
Clinical and epidemiological observations on individual radiation sensitivity and susceptibility
Seibold, P., Auvinen, A., Averbeck, D., Bourguignon, M., Hartikainen, J. M., Hoeschen, C., Laurent, O., Noël, G., Sabatier, L., Salomaa, S., et al. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1665209 · Cited by 56
“Cardiac doses from breast cancer radiotherapy were previously associated with increased cardiovascular mortality (Darby et al. 2013).”
BackgroundCardiac Computed Tomography in Cardio-Oncology
Lopez‐Mattei, J., Yang, E. H., Ferencik, M., Baldassarre, L. A., Dent, S. F., & Budoff, M. J. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.09.010 · Cited by 63
“RT has been directly associated with the development of accelerated atherosclerosis and development of future coronary events, dependent on the heart dose received (41).”
BackgroundConsequences of ionizing radiation exposure to the cardiovascular system
Jahng, J. W. S., Little, M. P., No, H. J., Loo, B. W., & Wu, J. C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01056-4 · Cited by 67
“…is well known for its cardioprotective properties in premenopausal women 203 , and the replenishment of oestrogen via hormone replacement therapy has been shown to significantly reduce the risk of coronary complications in patients with breast cancer who have undergone radiation therapy 91,93 .”
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Bartlett, F. R., Colgan, R. M., Donovan, E. M., Carr, K., Landeg, S., Clements, N., McNair, H. A., Locke, I., Evans, P., Haviland, J., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/51578-v · Cited by 56
Lo, Q., Hee, L., Batumalai, V., Allman, C., Macdonald, P. S., Delaney, G. P., Lonergan, D., & Thomas, L. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.11.016 · Cited by 56
Revised estimates of overdiagnosis from the Canadian National Breast Screening Study
Baines, C. J., To, T. M., & Miller, A. B. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.06.033 · Cited by 56
Fradley, M. G., Brown, A. C., Shields, B., Viganego, F., Damrongwatanasuk, R., Patel, A., Hartlage, G. R., Roper, N., Jaunese, J., Roy, L., et al. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.340 · Cited by 56
Azizova, T. V., Batistatou, E., Grigoryeva, E. S., McNamee, R., Wakeford, R., Liu, H., de Vocht, F., & Agius, R. M. (2018) · Radiation Research · doi:10.1667/rr14468.1 · Cited by 60
Long-term risks of secondary cancer for various whole and partial breast irradiation techniques
Hoekstra, N., Fleury, E., Merino, T., van der Baan, P., Bahnerth, A., Struik, G. M., Hoogeman, M. S., & Pignol, J. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.032 · Cited by 63
Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
Bertero, E., Ameri, P., & Maack, C. (2019) · Cardiac failure review · doi:10.15420/cfr.2019.1.2 · Cited by 62
“In fact, cardiac radiation dose correlates with the subsequent risk of ischaemic heart disease in breast cancer patients, and even low levels of exposure heighten the risk of coronary events.(32) Furthermore, a recent study observed that radiation therapy in breast cancer patients leads to a dose-dependent increase in…”
BackgroundHenson, K. E., McGale, P., Darby, S. C., Parkin, M., Wang, Y., & Taylor, C. (2020) · International Journal of Cancer · doi:10.1002/ijc.32908 · Cited by 61
Self-citationXu, C., Guo, L., Liao, Z. X., Wang, Y., Liu, X., Zhao, S., Wang, J., Yuan, Z., Wang, P., & Lin, S. H. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.04.016 · Cited by 64
“The dose to and the volume of heart irradiated influence the incidence, type, severity, and mortality associated with RICC [15,30,31].”
BackgroundCardiotoxicity in breast cancer treatment: Causes and mitigation
Valiyaveettil, D., Joseph, D. M., & Malik, M. (2023) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2023.100760 · Cited by 65
Zablotska, L. B., Little, M. P., & Cornett, R. J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt244 · Cited by 52
Rice, L., Goldsmith, C., Green, M., Cleator, S. J., & Price, P. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s130090 · Cited by 55
“4% per Gray of mean heart dose received.(1) As no apparent threshold has been determined for radiation-induced MCE, it implies that there is no “safe” limit; therefore, the dose to the heart should be kept as low as possible.”
Ade, C. J., Broxterman, R. M., Charvat, J. M., & Barstow, T. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005564 · Cited by 52
“Given the link between radiation exposure and risk of circulatory disease, additional work is required to determine the long-term CVD risk in astronauts performing longduration, deep-space missions.(23,24)”
BackgroundCardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
Caron, J. P., & Nohria, A. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0710-1 · Cited by 55
Yu, A. F., Ho, A. Y., Braunstein, L. Z., Thor, M., Chuy, K. L., Eaton, A. A., Mara, E., Cahlon, O., Dang, C. T., Oeffinger, K. C., et al. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.12.009 · Cited by 55
“0894-7317/$36.00 Copyright 2018 by the American Society of Echocardiography. https://doi.org/10.1016/j.echo.2018.12.009 521 Abbreviations 2D = Two-dimensional BCA = Breast cancer GCS = Global circumferential strain GLS = Global longitudinal strain GRS = Global radial strain HTN = Hypertension IMRT = Intensity-modulate…”
InfluentialCardiac death after breast radiotherapy and the QUANTEC cardiac guidelines
Beaton, L., Bergman, A. M., Nichol, A., Aparicio, M., Wong, G. C., Gondara, L., Speers, C. H., Weir, L. M., Davis, M. K., & Tyldesley, S. K. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.08.001 · Cited by 63
“It is also increasingly recognised that risk of RTassociated cardiovascular disease (CVD) may be affected by a patient’s baseline CVD risk factors (RFs) [6,7,11,17,18].”
BackgroundStability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer
Reitz, D., Walter, F., Schönecker, S., Freislederer, P., Pazos, M., Niyazi, M., Landry, G., Alongi, F., Bölke, E., Matuschek, C., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01572-w · Cited by 54
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation
Brunt, A. M., Haviland, J., Kirby, A. M., Somaiah, N., Wheatley, D. A., Bliss, J. M., & Yarnold, J. R. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.04.016 · Cited by 54
“[22] have shown that there is no safe dose to the heart and therefore the effort is to reduce or eliminate cardiac dose.”
BackgroundPoortmans, P. M., Struikmans, H., Brouwer, P. D., Weltens, C. G., Fortpied, C., Kirkove, C., Budach, V., Peignaux-Casasnovas, K., van der Leij, F., Vonk, E. J. A., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab113 · Cited by 54
Lu, Y., Yang, D., Zhang, X., Teng, Y., Yuan, W., Zhang, Y., He, R., Tang, F., Pang, J., Han, B. R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845037 · Cited by 54
“, radiation-related heart disease (RRHD) (3) and radiation pneumonia (RP) (4)] with an increased risk of secondary cancer (3, 5–9).”
BackgroundMethodResultInfluentialJones, L. W., Douglas, P. S., Khouri, M. G., Mackey, J. R., Wojdyla, D., Kraus, W. E., Whellan, D. J., & O'Connor, C. M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5724 · Cited by 53
Rose, F. D., Fogliata, A., Franceschini, D., Navarria, P., Villa, E., Iftode, C., D’Agostino, G. R., Cozzi, L., Lobefalo, F., Mancosu, P., et al. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0701-z · Cited by 54
“[38], for conventional fractionation schemes, correlated the risk of ischemic heart disease with dose, estimating an increased risk of 7.”
BackgroundMoustakis, C., Blanck, O., Tazehmahalleh, F. E., Chan, M. K. H., Ernst, I., Krieger, T., Duma, M. N., Oechsner, M., Ganswindt, U., Heinz, C. H., et al. (2017) · Strahlentherapie und Onkologie · doi:10.1007/s00066-017-1151-8 · Cited by 55
“Especially the heart may warrant further investigation concerning long-term side effects; however, cardiac doses should be minimized [35, 36].”
Influence of specific comorbidities on survival after early-stage breast cancer
Ewertz, M., Land, L. H., Dalton, S. O., Cronin-Fenton, D. P., & Jensen, M. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1407496 · Cited by 54
“Radiotherapy increases the risk of a myocardial infarction, particularly for left-sided breast cancers, and this risk is 3–5fold increased for women with prior ischemic heart disease [16,17].”
BackgroundSelf-citationJagsi, R., Griffith, K. A., Moran, J. M., Ficaro, E., Marsh, R. B., Dess, R. T., Chung, E., Liss, A. L., Hayman, J. A., Mayo, C. S., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.04.075 · Cited by 54
Geneviève, L. D., Martani, A., Mallet, M. C., Wangmo, T., & Elger, B. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226015 · Cited by 55
“2013 [92] DK Cross-national Health Services; Public Health 1 4 Dastani et al.”
BackgroundDEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways
Sautter‐Bihl, M., Sedlmayer, F., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Fussl, C., Haase, W., Harms, W., Piroth, M. D., et al. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0543-7 · Cited by 54
“The restrictive use of IMN-RT accounts for the apprehension of enhanced cardiac toxicity [8, 12].”
BackgroundTyran, M., Mailleux, H., Tallet, A. R., Fau, P., Gonzague, L., Minsat, M., Moureau-Zabotto, L., & Resbeut, M. (2015) · Journal of Radiation Research · doi:10.1093/jrr/rrv052 · Cited by 53
“[36] described a linear relationship between the mean dose to the heart and cardiac events.”
Background
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.